ResMed Inc. (NYSE:RMD) Q3 2026 Earnings Call Transcript
Operator: Welcome to the Q3 Fiscal Year 2026 ResMed Inc. Earnings Conference Call. My name is Daryl, and I will be your operator for today's call.
Resmed Inc (RMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 450,250 | $101,072,120 | +65% | 0.05% |
| 2. | Ilex Capital Partners Jonas Diedrich And David Sutton | 413,855 | $92,902,170 | +69% | 2.29% |
| 3. | 400,000 | $89,792,000 | 7.22% | ||
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 381,296 | $85,593,329 | 0.09% | |
| 5. | AQR Capital Management Cliff Asness | 349,840 | $77,797,404 | +37% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.13 | 2,487 | $171,926.31 | 19,216 | 2016-08-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $207.82 | 4,991 | $1,037,232.61 | 466,223 | 2026-05-07 | Filing | |
| $225.50 | 4,991 | $1,125,486.47 | 466,223 | 2026-04-07 | Filing | |
| $224.31 | 1,000 | $224,310.00 | 83,495 | 2026-04-01 | Filing | |
| $225.00 | 2,000 | $450,000.00 | 60,773 | 2026-04-01 | Filing | |
| $251.03 | 4,991 | $1,252,901.71 | 466,223 | 2026-03-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,094,023 | $2,714,866,496 | 0.05% | |
| 2. | 9,466,416 | $2,125,021,063 | 0.05% | |
| 3. | 7,863,922 | $1,765,293,211 | 0.09% | |
| 4. | 6,643,168 | $1,491,258,353 | 0.05% | |
| 5. | 4,925,386 | $1,105,650,719 | 0.2% |
News See All
8 Best Long-Term ASX Stocks to Buy Right Now
Based on Reuters’ report dated April 14, 2026, consumer sentiment in Australia has softened significantly, as highlighted by the Westpac-Melbourne Institute Index’s 12.5% drop to 80.1 in April, its...
ResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings
ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc.
10 Best Medical Technology Stocks to Invest In
Medical technology, or MedTech, companies ensure that the broader healthcare industry has the tools needed to diagnose, treat, monitor, or prevent medical conditions.
ResMed Inc. (RMD): A Bull Case Theory
We came across a bullish thesis on ResMed Inc. on Best Anchor Stocks’s Substack. In this article, we will summarize the bulls’ thesis on RMD.
ResMed Inc. (NYSE:RMD) Q2 2026 Earnings Call Transcript
Operator: Greetings, and welcome to the ResMed Second Quarter Fiscal Year 2026 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded.
ResMed Inc. (NYSE:RMD) Q1 2026 Earnings Call Transcript
Operator: Hello, and welcome to the Q1 Fiscal Year 2026 ResMed Earnings Conference Call. My name is Kevin. I'll be your operator for today's call.
ResMed Inc. (RMD): A Bull Case Theory
We came across a bullish thesis on ResMed Inc. on CompoundingLab’s Substack. In this article, we will summarize the bulls’ thesis on RMD.
ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress
ResMed Inc. (NYSE:RMD) is a leading health technology company focused on sleep, breathing, and home care solutions.
7 Hot Healthcare Stocks to Buy Right Now
The majority of Americans have experienced the annoyance of having their health insurance rejected, frequently without any recourse after contacting carriers by email and phone. Dr.